Motivations and concerns about adolescent tuberculosis vaccine trial participation in rural Uganda: a qualitative study
- PMID: 26834929
- PMCID: PMC4725648
- DOI: 10.11604/pamj.2015.22.76.7097
Motivations and concerns about adolescent tuberculosis vaccine trial participation in rural Uganda: a qualitative study
Abstract
Introduction: Research is being carried out to develop and test new potentially more effective tuberculosis vaccines. Among the vaccines being developed are those that target adolescents. This study explored the stakeholders' perceptions about adolescent participation in a hypothetical tuberculosis vaccine trial in Ugandan adolescents.
Methods: Focus group discussions with adolescents, parents of infants and adolescents, and key informant interviews with community leaders and traditional healers were conducted.
Results: The majority of the respondents expressed potential willingness to allow their children participate in a tuberculosis vaccine trial. Main motivations for potential participation would be being able to learn about health-related issues. Hesitations included the notion that trial participation would distract the youths from their studies, fear of possible side effects of an investigational product, and potential for being sexually exploited by researchers. In addition, bad experiences from participation in previous research and doubts about the importance of research were mentioned. Suggested ways to motivate participation included: improved clarity on study purpose, risks, benefits and better scheduling of study procedures to minimize disruption to participants' academic schedules.
Conclusion: Findings from this study suggest that the community is open to potential participation of adolescents in a tuberculosis vaccine trial. However, there is a need to communicate more effectively with the community about the purpose of the trial and its effects, including safety data, in a low-literacy, readily understood format. This raises a challenge to researchers, who cannot know all the potential effects of a trial product before it is tested.
Keywords: Uganda; Willingness to participate; adolescents; hypothetical tuberculosis vaccine; qualitative study; trial.
Similar articles
-
Are adolescents ready for tuberculosis vaccine trials?Vaccine. 2008 Aug 26;26(36):4725-30. doi: 10.1016/j.vaccine.2008.06.088. Epub 2008 Jul 11. Vaccine. 2008. PMID: 18620015
-
Engaging adolescents in tuberculosis and clinical trial research through drama.Trials. 2016 Apr 6;17:177. doi: 10.1186/s13063-016-1291-7. Trials. 2016. PMID: 27048474 Free PMC article.
-
Tuberculosis knowledge, attitudes and health-seeking behaviour in rural Uganda.Int J Tuberc Lung Dis. 2011 Jul;15(7):938-42. doi: 10.5588/ijtld.10.0211. Int J Tuberc Lung Dis. 2011. PMID: 21682968
-
Improving adolescent health: focus on HPV vaccine acceptance.J Adolesc Health. 2005 Dec;37(6 Suppl):S17-23. doi: 10.1016/j.jadohealth.2005.09.010. J Adolesc Health. 2005. PMID: 16310137 Review.
-
More than the money: a review of the literature examining healthy volunteer motivations.Contemp Clin Trials. 2011 May;32(3):342-52. doi: 10.1016/j.cct.2010.12.003. Epub 2010 Dec 10. Contemp Clin Trials. 2011. PMID: 21146635 Free PMC article. Review.
Cited by
-
Children as controls in research; The voice of the volunteer.PLoS One. 2025 Jun 3;20(6):e0325069. doi: 10.1371/journal.pone.0325069. eCollection 2025. PLoS One. 2025. PMID: 40460076 Free PMC article.
-
Know your tuberculosis epidemic-Is it time to add Mycobacterium tuberculosis immunoreactivity back into global surveillance?PLOS Glob Public Health. 2022 Oct 24;2(10):e0001208. doi: 10.1371/journal.pgph.0001208. eCollection 2022. PLOS Glob Public Health. 2022. PMID: 36962621 Free PMC article. Review.
-
Lessons from the first clinical trial of a non-licensed vaccine among Ugandan adolescents: a phase II field trial of the tuberculosis candidate vaccine, MVA85A.Wellcome Open Res. 2018 Sep 19;3:121. doi: 10.12688/wellcomeopenres.14736.1. eCollection 2018. Wellcome Open Res. 2018. PMID: 30687792 Free PMC article.
-
Tuberculosis Immunoreactivity Surveillance in Malawi (Timasamala)-A protocol for a cross-sectional Mycobacterium tuberculosis immunoreactivity survey in Blantyre, Malawi.PLoS One. 2024 May 24;19(5):e0291215. doi: 10.1371/journal.pone.0291215. eCollection 2024. PLoS One. 2024. PMID: 38787869 Free PMC article.
-
Family-Centered Care Experiences in Elderly with Chronic Diseases in Communities: Qualitative Study of Patients, Families, Nurses, and Volunteers.Health Equity. 2024 Jun 5;8(1):338-350. doi: 10.1089/heq.2024.0009. eCollection 2024. Health Equity. 2024. PMID: 39011075 Free PMC article.
References
-
- Beresford B, Sadoff JC. Update on research and development pipeline: tuberculosis vaccines. Clinical Infectious Diseases. 2010;50(Supplement 3):S178–S183. - PubMed
-
- WHO. The Stop TB Strategy: building on and enhancing DOTS to meet the TB related Millennium Development Goals. Geneva, Switzerland: World Health Organization; 2006.
-
- Colditz GA, et al. Efficacy of BCG vaccine in the prevention of tuberculosis: meta-analysis of the published literature. Jama. 1994;271(9):698–702. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials